Organization | Vaxtrials S.A.

Vaxtrials S.A. Report issue

For profit Phase 2 Phase 3

Founded: Panama City Panama (2002)

Organization Overview

First Clinical Trial

2014

NCT02111135

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2018

Timeline

NOW

Now

Alternative names

Vaxtrials S.A.

Active Ingredients

Drugs in Phase 3 Trials (2)

ipv-al ssi (2 trials)

Drugs in Phase 2 Trials (4)

bivalent oral polio vaccine (bopv), type 1 and type 3 (1 trial)

inactivated poliovirus type 2 vaccine (1 trial)

m-ipv hd (1 trial)

monovalent oral polio vaccines (mopv2) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Poliomyelitis (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 3
# of Trial APIs: 6